OBJECTIVE: The authors analyzed the effectiveness and therapeutic response of Novalis shaped beam radiosurgery for metastatic brain tumors, and the prognostic factors which influenced the outcome. METHODS: We performed a retrospective analysis of 106 patients who underwent 159 treatments for 640 metastatic brain lesions between January 2000 and April 2008. The pathologies of the primary tumor were mainly lung (45.3%), breast (18.2%) and GI tract (13.2%). We classified the patients using Radiation Therapy Oncology Group Recursive Partitioning Analysis (RPA) and then analyzed the survival and prognostic factors according to the Kaplan Meier method and univariate analysis. RESULTS: The overall median actuarial survival rate was 7.3 months from the time of first radiosurgery treatment while 1 and 2 year actuarial survival estimates were 31% and 14.4%, respectively. Median actuarial survival rates for RPA classes I, II, and III were 31.3 months, 7.5 months and 1.7 months, respectively. Patients' life spans, higher Karnofsky performance scores and age correlated closely with RPA classes. However, sex and the number of lesions were not found to be significantly associated with length of survival. CONCLUSION: This result suggests that Novalis radiosurgery can be a good treatment option for treatment of the patients with brain metastases.
OBJECTIVE: The authors analyzed the effectiveness and therapeutic response of Novalis shaped beam radiosurgery for metastatic brain tumors, and the prognostic factors which influenced the outcome. METHODS: We performed a retrospective analysis of 106 patients who underwent 159 treatments for 640 metastatic brain lesions between January 2000 and April 2008. The pathologies of the primary tumor were mainly lung (45.3%), breast (18.2%) and GI tract (13.2%). We classified the patients using Radiation Therapy Oncology Group Recursive Partitioning Analysis (RPA) and then analyzed the survival and prognostic factors according to the Kaplan Meier method and univariate analysis. RESULTS: The overall median actuarial survival rate was 7.3 months from the time of first radiosurgery treatment while 1 and 2 year actuarial survival estimates were 31% and 14.4%, respectively. Median actuarial survival rates for RPA classes I, II, and III were 31.3 months, 7.5 months and 1.7 months, respectively. Patients' life spans, higher Karnofsky performance scores and age correlated closely with RPA classes. However, sex and the number of lesions were not found to be significantly associated with length of survival. CONCLUSION: This result suggests that Novalis radiosurgery can be a good treatment option for treatment of the patients with brain metastases.
Authors: Paul W Sperduto; Brian Berkey; Laurie E Gaspar; Minesh Mehta; Walter Curran Journal: Int J Radiat Oncol Biol Phys Date: 2007-10-10 Impact factor: 7.038
Authors: E Weltman; J V Salvajoli; R A Brandt; R de Morais Hanriot; F E Prisco; J C Cruz; S R de Oliveira Borges; D B Wajsbrot Journal: Int J Radiat Oncol Biol Phys Date: 2000-03-15 Impact factor: 7.038
Authors: A Schöggl; K Kitz; M Reddy; S Wolfsberger; B Schneider; K Dieckmann; K Ungersböck Journal: Acta Neurochir (Wien) Date: 2000 Impact factor: 2.216
Authors: M A Chidel; J H Suh; C A Reddy; S T Chao; M F Lundbeck; G H Barnett Journal: Int J Radiat Oncol Biol Phys Date: 2000-07-01 Impact factor: 7.038
Authors: M Klein; M J Taphoorn; J J Heimans; H M van der Ploeg; W P Vandertop; E F Smit; S Leenstra; C A Tulleken; W Boogerd; J S Belderbos; W Cleijne; N K Aaronson Journal: J Clin Oncol Date: 2001-10-15 Impact factor: 44.544
Authors: Dirk Rades; Andre Pluemer; Theo Veninga; Patrick Hanssens; Juergen Dunst; Steven E Schild Journal: Cancer Date: 2007-11-15 Impact factor: 6.860
Authors: Brian Patrick O'Neill; Nancy J Iturria; Michael J Link; Bruce E Pollock; Karla V Ballman; Judith R O'Fallon Journal: Int J Radiat Oncol Biol Phys Date: 2003-04-01 Impact factor: 7.038